|
1
|
Storz P and Crawford HC: Carcinogenesis of
pancreatic ductal adenocarcinoma. Gastroenterology. 158:2072–2081.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Latenstein AEJ, van der Geest LGM, Bonsing
BA, Groot Koerkamp B, Haj Mohammad N, de Hingh IHJT, de Meijer VE,
Molenaar IQ, van Santvoort HC, van Tienhoven G, et al: Nationwide
trends in incidence, treatment and survival of pancreatic ductal
adenocarcinoma. Eur J Cancer. 125:83–93. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter K, Talar-Wojnarowska R, Dąbrowski
A, Degowska M, Durlik M, Gąsiorowska A, Głuszek S, Jurkowska G,
Kaczka A, Lampe P, et al: Diagnostic and therapeutic
recommendations in pancreatic ductal adenocarcinoma.
Recommendations of the working group of the Polish pancreatic club.
Prz Gastroenterol. 14:1–18. 2019.PubMed/NCBI
|
|
6
|
Sarantis P, Koustas E, Papadimitropoulou
A, Papavassiliou AG and Karamouzis MV: Pancreatic ductal
adenocarcinoma: Treatment hurdles, tumor microenvironment and
immunotherapy. World J Gastrointest Oncol. 12:173–181. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rishi A, Goggins M, Wood LD and Hruban RH:
Pathological and molecular evaluation of pancreatic neoplasms.
Semin Oncol. 42:28–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hackeng WM, Hruban RH, Offerhaus GJ and
Brosens LA: Surgical and molecular pathology of pancreatic
neoplasms. Diagn Pathol. 11:472016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vivekanandhan S, Madamsetty VS, Angom RS,
Dutta SK, Wang E, Caulfield T, Pletnev AA, Upstill-Goddard R,
Asmann YW, Chang D, et al: Role of PLEXIND1/TGFβ signaling axis in
pancreatic ductal adenocarcinoma progression correlates with the
mutational status of KRAS. Cancers (Basel). 13:40482021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sinn M, Sinn BV, Treue D, Keilholz U, Damm
F, Schmuck R, Lohneis P, Klauschen F, Striefler JK, Bahra M, et al:
TP53 mutations predict sensitivity to adjuvant gemcitabine in
patients with pancreatic ductal adenocarcinoma: Next-generation
sequencing results from the CONKO-001 trial. Clin Cancer Res.
26:3732–3739. 2020.PubMed/NCBI
|
|
11
|
Gao J, Chen X, Li X, Miao F, Fang W, Li B,
Qian X and Lin X: Differentiating TP53 mutation status in
pancreatic ductal adenocarcinoma using multiparametric MRI-derived
radiomics. Front Oncol. 11:6321302021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eger N, Schoppe L, Schuster S, Laufs U and
Boeckel JN: Circular RNA splicing. Adv Exp Med Biol. 1087:41–52.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du WW, Fang L, Yang W, Wu N, Awan FM, Yang
Z and Yang BB: Induction of tumor apoptosis through a circular RNA
enhancing Foxo3 activity. Cell Death Differ. 24:357–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu
Y, Liu X, Cheng W, Wei YQ, Peng Y and Li W: RNA-Seq profiling of
circular RNA in human lung adenocarcinoma and squamous cell
carcinoma. Mol Cancer. 18:1342019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dube U, Del-Aguila JL, Li Z, Budde JP,
Jiang S, Hsu S, Ibanez L, Fernandez MV, Farias F, Norton J, et al:
An atlas of cortical circular RNA expression in Alzheimer disease
brains demonstrates clinical and pathological associations. Nat
Neurosci. 22:1903–1912. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao
F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel Role of FBXW7
circular RNA in repressing glioma tumorigenesis. J Natl Cancer
Inst. 110:304–305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Salzman J: Circular RNA expression: Its
potential regulation and function. Trends Genet. 32:309–316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ameli-Mojarad M, Ameli-Mojarad M,
Hadizadeh M, Young C, Babini H, Nazemalhosseini-Mojarad E and Bonab
MA: The effective function of circular RNA in colorectal cancer.
Cancer Cell Int. 21:4962021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian T, Zhao Y, Zheng J, Jin S, Liu Z and
Wang T: Circular RNA: A potential diagnostic, prognostic, and
therapeutic biomarker for human triple-negative breast cancer. Mol
Ther Nucleic Acids. 26:63–80. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qu S, Song W, Yang X, Wang J, Zhang R,
Zhang Z, Zhang H and Li H: Microarray expression profile of
circular RNAs in human pancreatic ductal adenocarcinoma. Genom
Data. 5:385–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo S, Xu X, Ouyang Y, Wang Y, Yang J, Yin
L, Ge J and Wang H: Microarray expression profile analysis of
circular RNAs in pancreatic cancer. Mol Med Rep. 17:7661–7671.
2018.PubMed/NCBI
|
|
24
|
Li H, Hao X, Wang H, Liu Z, He Y, Pu M,
Zhang H, Yu H, Duan J and Qu S: Circular RNA expression profile of
pancreatic ductal adenocarcinoma revealed by microarray. Cell
Physiol Biochem. 40:1334–1344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van Roessel S, Kasumova GG, Verheij J,
Najarian RM, Maggino L, de Pastena M, Malleo G, Marchegiani G,
Salvia R, Ng SC, et al: International validation of the eighth
edition of the American joint committee on cancer (AJCC) TNM
staging system in patients with resected pancreatic cancer. JAMA
Surg. 153:e1836172018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Crea F, Quagliata L, Michael A, Liu HH,
Frumento P, Azad AA, Xue H, Pikor L, Watahiki A, Morant R, et al:
Integrated analysis of the prostate cancer small-nucleolar
transcriptome reveals SNORA55 as a driver of prostate cancer
progression. Mol Oncol. 10:693–703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Sang J, Zhang Y, Gao L, Zhao D and
Cao H: Circular RNA ITCH attenuates the progression of
nasopharyngeal carcinoma by inducing PTEN upregulation via miR-214.
J Gene Med. e33912021.(Online ahead of print). PubMed/NCBI
|
|
30
|
Zhu Z, Huang R and Huang B: Predicting
functional circular RNA-based competitive endogenous RNA network in
gastric carcinoma using novel bioinformatics analysis. Exp Biol Med
(Maywood). 153537022110487572021.(Epub ahead of print). PubMed/NCBI
|
|
31
|
Chen Y, Li Z, Zhang M, Wang B, Ye J, Zhang
Y, Tang D, Ma D, Jin W, Li X and Wang S: Circ-ASH2L promotes tumor
progression by sponging miR-34a to regulate Notch1 in pancreatic
ductal adenocarcinoma. J Exp Clin Cancer Res. 38:4662019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L,
Li Z, Jiang D, Kong Y, Li Z, et al: Circular RNA circBFAR promotes
the progression of pancreatic ductal adenocarcinoma via the
miR-34b-5p/MET/Akt axis. Mol Cancer. 19:832020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xiao Y: Construction of a
circRNA-miRNA-mRNA network to explore the pathogenesis and
treatment of pancreatic ductal adenocarcinoma. J Cell Biochem.
121:394–406. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Q, Geng S, Yuan H, Li Y, Zhang S, Pu L,
Ge J, Niu X, Li Y and Jiang H: Circular RNA expression profiles in
extracellular vesicles from the plasma of patients with pancreatic
ductal adenocarcinoma. FEBS Open Bio. 9:2052–2062. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Y, Yao Y, Gao P and Cui Y: Upregulated
circular RNA circ_0030235 predicts unfavorable prognosis in
pancreatic ductal adenocarcinoma and facilitates cell progression
by sponging miR-1253 and miR-1294. Biochem Biophys Res Commun.
509:138–142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hao L, Rong W, Bai L, Cui H, Zhang S, Li
Y, Chen D and Meng X: Upregulated circular RNA circ_0007534
indicates an unfavorable prognosis in pancreatic ductal
adenocarcinoma and regulates cell proliferation, apoptosis, and
invasion by sponging miR-625 and miR-892b. J Cell Biochem.
120:3780–3789. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiang Y, Wang T, Yan L and Qu L: A novel
prognostic biomarker for pancreatic ductal adenocarcinoma:
hsa_circ_0001649. Gene. 675:88–93. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tang Q, Chen Z, Zhao L and Xu H: circular
RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical
cancer progression through up-regulation of ELK1. Aging (Albany
NY). 11:9982–9999. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xia F, Chen Y, Jiang B, Bai N and Li X:
Hsa_circ_0011385 accelerates the progression of thyroid cancer by
targeting miR-361-3p. Cancer Cell Int. 20:492020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ji Y, Sun Q, Zhang J and Hu H: MiR-615
inhibits cell proliferation, migration and invasion by targeting
EGFR in human glioblastoma. Biochem Biophys Res Commun.
499:719–726. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guan X, Zong ZH, Liu Y, Chen S, Wang LL
and Zhao Y: circPUM1 promotes tumorigenesis and progression of
ovarian cancer by sponging miR-615-5p and miR-6753-5p. Mol Ther
Nucleic Acids. 18:882–892. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen Y, Guo Y and Yan W: lncRNA
RP5-916L7.2 correlates with advanced tumor stage, and promotes
cells proliferation while inhibits cells apoptosis through
targeting miR-328 and miR-939 in tongue squamous cell carcinoma.
Clin Biochem. 67:24–32. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen A, Liu S, Lu X, Wei L and Chen Y:
Inhibition of microRNA-939 suppresses the development of human
non-small cell lung cancer via the upregulation of tissue inhibitor
of metalloproteinases 2. Mol Med Rep. 18:4831–4838. 2018.PubMed/NCBI
|
|
44
|
Rachinger N, Fischer S, Bohme I, Böhme I,
Linck-Paulus L, Kuphal S, Kappelmann-Fenzl M and Bosserhoff AK:
Loss of gene information: Discrepancies between RNA sequencing,
cDNA microarray, and qRT-PCR. Int J Mol Sci. 22:93482021.
View Article : Google Scholar
|
|
45
|
Xu T, Wu J, Han P, Zhao Z and Song X:
Circular RNA expression profiles and features in human tissues: A
study using RNA-seq data. BMC Genomics. 18 (Suppl 6):S6802017.
View Article : Google Scholar
|
